Counseling may prove effective in patients with CVD risk factors

Publication
Article
Cardiology Review® OnlineFebruary 2009
Volume 26
Issue 2

A 45-year-old woman presented to our institution for cardiovascular risk assessment. The patient had no personal or family history of cardiovascular disease (CVD), but reported smoking 1 pack of cigarettes daily. She noted exercising occasionally without symptomatic limitations.

A 45-year-old woman presented to our institution for cardiovascular risk assessment. The patient had no personal or family history of cardiovascular disease (CVD), but reported smoking 1 pack of cigarettes daily. She noted exercising occasionally without symptomatic limitations.

On physical examination, the patient appeared to be healthy, despite being overweight (body mass index, 28.7 kg/m2). Her blood pressure was 138/75 mm Hg in both arms, and the examination was otherwise normal. Laboratory studies revealed a fasting blood glucose of 94 mg/dL, total cholesterol of 185 mg/dL, and high-density lipoprotein cholesterol of 51 mg/dL. Her serum creatinine was normal. A resting electrocardiogram (ECG) showed nonspecific ST-segment and T-wave abnormalities. The presence of these abnormalities did not prompt additional testing because a high proportion of false-positive ECG abnormalities are known to occur in individuals in the patient’s age range.

Although the patient’s absolute 10-year risk for coronary heart disease was low, her heavy smoking history was associated with a marked increase in her relative CVD risk in the short-term. The patient noted having significant difficulty in stopping smoking in the past, but an extensive discussion with her regarding the marked short-term risks of smoking in women translated into successful smoking cessation over the next 3 months.

Related Videos
Video 2 - "Lessons from EXPLORER-HCM: Unveiling CMIs' Potential in oHCM Treatment "
Video 1 - "Novel Cardio Myosin Inhibitors Targeting Obstructive Hypertrophic Cardiomyopathy's Root Cause "
A panel of 5 cardiovascular experts
A panel of 5 cardiovascular experts
Heart Failure Treatment Outcomes and Contraindications
Patient Involvement in Advanced HF Treatment, with Ashley Malliett, DMSc, MPAS, PA-C
Tailoring Chest Pain Diagnostics to Patients, with Kyle Fortman, PA-C, MBA
Kyle Fortman, PA-C, MBA: Troponin and Heart Injury Risk Screening Recommendations
What Should the American Academy of Physician Associates Focus on in 2025?
The Rising Rate of Heat-Related Illness, with Janelle Bludhorn, PA-C
© 2024 MJH Life Sciences

All rights reserved.